Berikutnya

Putar otomatis

Bevacizumab’s Role in Recurrent Ovarian Cancer

6 Tampilan • 07/01/23
Membagikan
Menanamkan
administrator
administrator
Pelanggan
0

Expert perspectives on bevacizumab’s role in recurrent ovarian cancer, particularly in light of recent PARP inhibitor strategies.

Website: https://www.onclive.com
Twitter: https://twitter.com/OncLive
Facebook: https://www.facebook.com/OncLive/
LinkedIn: https://www.linkedin.com/company/onclive

Menampilkan lebih banyak
0 Komentar sort Sortir dengan
Komentar Facebook

Berikutnya

Putar otomatis